Breast cancer is by far the commonest cancer in women; more than 1 million women world wide are diagnosed with breast cancer every year. Treatment options of breast cancer are surgery, radiation and chemotherapy. Although there have been significant advances in breast cancer treatment over the past several decades, current therapeutic approaches are limited by non-specific systemic distribution, inadequate drug concentrations reaching the tumor and multidrug resistance.The application of nanotechnology to medicine helps to overcome limitations relating to chemotherapy. Nanoparticles with enhanced surface properties are able to diffuse with greater ease inside the tumor cells delivering a high amount of drug selectively to tumor cells with significant reduced toxicity.In the near future, the use of nanotechnology could revolutionize the entire of breast cancer treatment. The present review examined some of the approved nanocarrier-based drugs for treatment of breast cancer. Also, other drugs under development or in preclinical trials to be used in the near future will be discussed.
303 Absract views 4 PDF Downloads 307 Total views
HER-2 targeted immunonanoparticles for breast cancer chemotherapyRitu Dhankar, Parmender Rathee, Arvind K Jain, Sahil Arora, Murugesan Senthil Kumar, Goutam Rath, Ajit Kumar Saxena, P.R. Sharma, Gousia Chashoo, Amit K. Goyal
Assessing the potential of gastroretentive technology for gastric cancer targetingSwati Saini, Jatin Chhabra, Archana Sharma, Manish Kumar, Inderbir Singh, Rakesh Pahwa
Development of Lipid Based Nanoparticulate Drug Delivery Systems and Drug Carrier Complexes for Delivery to Brain
Nano Technology: A ReviewManivannan Rangasamy